Purdue Continued Pitching OxyContin Despite Concerns Raised By Sales Reps, New Suit From Pennsylvania Alleges
By Editor - Wed May 15, 9:09 am
The suit says Purdue Pharma drug representatives made 531,000 calls on doctors in the state since 2007, when the company settled with Pennsylvania and 25 other states and agreed to stop illegal diversion of OxyContin and to promote it only for federally approved uses. The company is facing a barrage of legal challenges from local counties, states and other parties eager to hold it accountable for the role it played in the opioid epidemic.
Originally posted here: